Thursday, November 10, 3:00pm - 4:20pm (EST)
Time zone
am/pm
24h
Suggestions
Your search did not return any results.
This Oral Abstract presentation will review baseline and acquired resistance development in newer drugs for the treatment of tuberculosis, as well as future predictions for drug resistance profiles and the use of artificial intelligence in determining sequencing and drug-susceptibility.</p>
Please see the online program for additional details: https://conf2022.theunion.org/wp-content/uploads/2022/09/Community-Connect-Programme-Schedule-1.pdf